Valion Bio president, COO and CFO Lisa Wolf to resign effective Dec. 11, 2026
VBIO•Valion Bio President, COO and CFO Lisa Wolf will voluntarily resign effective Dec. 11, 2026, after notifying the board’s Special Committee on Oct. 31, 2026.
1. Resignation announced
Lisa Wolf will voluntarily resign as Valion Bio’s president, chief operating officer and chief financial officer effective Dec. 11, 2026. She notified the board’s Special Committee of her decision on Oct. 31, 2026.
